Mechanism of action of thalidomide elucidated

July 17, 2014, Friedrich Miescher Institute for Biomedical Research
Mechanism of action of thalidomide elucidated
Crystal structure of thalidomide (yellow calotte model) bound to CRBN (green, blue and cyan) and DDB1 (yellow, grey, red and purple).

(Medical Xpress)—Scientists led by Nicolas Thomä at the Friedrich Miescher Institute for Biomedical Research have clarified the workings of thalidomide at the molecular level. Their analysis of various structures, published in Nature, indicates that the drug can interfere with cellular processes in two different ways—once preventing and once promoting protein degradation—thus explaining its diverse clinical effects.

In the early 1960s, – a drug widely prescribed at that time as a sedative and for the treatment of morning sickness in pregnancy – became notorious when it was found to cause birth defects. The product was subsequently withdrawn from the market. In the late 1990s, however, thalidomide and its derivatives were shown to be effective in the treatment of certain types of blood cancer, and the drug has come back into use – subject to strict safety requirements.

In a study published in Nature, Nicolas Thomä and his group of structural biologists at the Friedrich Miescher Institute for Biomedical Research have now revealed how thalidomide interacts with its in the cell, giving rise to the different kinds of clinical effects.

Thalidomide has been known to interact with a large complex known as DDB1-CRBN. DDB1-CRBN is part of a major system, which uses the molecular tag ubiquitin to mark various proteins for degradation. Such complexes are also known as E3 ubiquitin ligases.

With the aid of crystal structures of thalidomide and its derivatives bound to DDB1-CRBN, the scientists found that, depending on cell type and configuration, thalidomide either activates or inhibits DDB1-CRBN. In the first case, which is relevant to the treatment of , thalidomide promotes the attachment of ubiquitin to two proteins known as Ikaros and Aiolos. Thalidomide recruits these two transcription factors to the realm of the ubiquitin ligase action.

In the second case, thalidomide blocks a normal substrate from binding to DDB1-CRBN. The binding partner in question – previously unknown – was identified as MEIS2, a protein involved in various aspects of human development. Thalidomide thus prevents MEIS2 from binding to DDB1-CRBN and degradation.

Thomä comments: "We're convinced that our findings provide initial evidence of how thalidomide and its derivatives can lead to both beneficial and extremely adverse clinical effects. Only with experiments like these will we be able in the future to produce compounds specifically designed to enhance the benefits and minimize the adverse effects."

Explore further: Victims: Thalidomide sold in Spain post-withdrawal

More information: Fischer ES, Böhm K, Lydeard JR, Yang H, Stadler MB, Cavadini S, Nagel J, Serluca F, Acker V, Lingaraju GM, Tichkule RB, Schebesta M, Forrester WC, Schirle M, Hassiepen U, Ottl J, Hild M, Beckwith REJ, Harper JW, Jenkins JL, Thomä NH (2014) (2014) "Structure of the DDB1 CRBN E3 ubiquitin ligase in complex with thalidomide." Nature. 2014 July 16 DOI: 10.1038/nature13527. [Epub ahead of print]

Related Stories

Victims: Thalidomide sold in Spain post-withdrawal

May 8, 2013
(AP)—Spanish victims of thalidomide on Wednesday published documents they claim prove a German drug company kept distributing the notorious drug in Spain six months after it was taken off the market in other countries.

Drug improves remission of Crohn disease among children and adolescents

November 26, 2013
Among children and adolescents with Crohn disease not responding to treatment, use of the drug thalidomide resulted in improved clinical remission after 8 weeks of treatment compared with placebo, according to a study appearing ...

Researchers discover precisely how thalidomide causes birth defects

April 19, 2011
Thalidomide may have been withdrawn in the early 1960s for use by pregnant women, but its dramatic effects remain memorable half a century later. Now, researchers have taken a major step toward understanding exactly how thalidomide ...

Recommended for you

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.